Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care
Abstract Wiskott Aldrich syndrome (WAS) is a rare disease and hematopoietic stem cell transplant (HCT) is considered the treatment modality of choice for WAS. We conducted a cross-sectional analysis on the KIDS’ pediatric inpatient database and compared hospitalization rates, complications and healt...
Guardado en:
Autores principales: | Nikki Agarwal, Divyaswathi Citla Sridhar, Sindhoosha Malay, Nirav Patil, Anjali Shekar, Sanjay Ahuja, Jignesh Dalal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/03219b2c17e24e6dbef06473680f994d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Analysis of clinical and molecular genetic characteristics of Wiskott-Aldrich syndrome and X-linked thrombocytopenia
por: Doina TURCAN, et al.
Publicado: (2021) -
Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome
por: Rajeev Rai, et al.
Publicado: (2020) -
Wiskott-Aldrich syndrome protein regulates autophagy and inflammasome activity in innate immune cells
por: Pamela P. Lee, et al.
Publicado: (2017) -
Trasplante alogénico de precursores hematopoyéticos en pacientes con síndrome de Wiskott-Aldrich
por: Wietstruck P,María Angélica, et al.
Publicado: (2007) -
Deletion of Wiskott–Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cells
por: Marisa A. P. Baptista, et al.
Publicado: (2016)